🟢 Cardio Diagnostics Holdings is trading 6.86% up in pre-market amid Nasdaq Composite's 0.51% pre-market rise

Cardio Diagnostics Holdings is trading at $2.18, up +6.86%, with the move appearing consistent with broader risk-on sentiment.

• The Nasdaq Composite was up 0.51% in pre-market context.
• No newly reported company-specific announcement emerged on August 17, 2026.
• The August 20 investor conference call remains the latest notable catalyst, covering commercial tests, reimbursement progress, and growth initiatives; recent volatility also followed the August 7 earnings release.